Blood type seems to matter mainly for the clot pathway
Inscribed in the molecular markers on our red blood cells, blood type has long seemed a neutral biological fact — yet a sweeping genomic study now suggests it may quietly shape the odds of stroke before age sixty. Analyzing genetic data from nearly 600,000 people across multiple continents, researchers found that carriers of blood type A face a modestly elevated early stroke risk, while those with type O appear somewhat protected. The finding does not call for alarm, but it invites a deeper reckoning with how the body's most intimate architecture — written into us before birth — participates in the unfolding of our health across a lifetime.
- A genome-wide study of 17,000 stroke cases found that blood type A raises early stroke risk by 16 percent, while type O lowers it by 12 percent — a statistically robust signal hiding inside a molecule most people never think about.
- The association vanishes in people over 60, suggesting that strokes in younger adults are driven by clot formation rather than the slow arterial decay that dominates late-life cases.
- Blood type B also showed an 11 percent elevated risk across all ages, hinting that multiple biological pathways connect these ancient molecular markers to vascular catastrophe.
- Researchers are candid about what they do not yet know: the precise mechanism linking blood type to clotting remains unresolved, and the study's population skewed heavily European, limiting how far the findings can travel.
- The absolute added risk for type A carriers remains small — not a mandate for extra screening, but a signal pointing researchers toward an underexplored corridor of stroke biology.
Your blood type, that quiet notation on a medical chart, may carry more consequence than most people imagine. A large genetic study found that people with type A blood face a 16 percent higher risk of stroke before age sixty, while those with the O1 variant enjoy a 12 percent reduction — findings drawn from one of the most comprehensive genomic analyses of early stroke ever assembled.
Researchers pooled data from 48 genetic studies involving roughly 17,000 stroke survivors and nearly 600,000 controls, all between 18 and 59 years old. A genome-wide search identified two genetic locations tied to early stroke risk, one of them sitting precisely where blood-type genes reside. The pattern was clear, though researchers were careful to emphasize that the absolute additional risk remains small — not a reason for type A individuals to seek extra screening or live in heightened worry.
The mechanism is not yet understood. The connection likely involves blood-clotting factors — platelets, vessel-lining cells, and circulating proteins — since type A blood has previously been linked to elevated clotting risk. But why the genetic blueprint for type A would predispose someone to these events remains an open question.
A revealing secondary finding emerged when the team examined strokes in people over 60: the type A association disappeared entirely. This suggests that early strokes operate through different biology than late-life ones — driven more by clot formation than by the slow arterial buildup that accumulates over decades. Type B blood also showed an 11 percent elevated risk regardless of age, complicating the picture further.
The study's authors, including vascular neurologist Steven Kittner of the University of Maryland, called for larger and more diverse research to confirm whether these patterns hold across different ancestry populations — only 35 percent of participants were of non-European descent. The work opens a door to stroke risk that had, until now, gone largely unexamined at this scale.
Your blood type, that simple designation on your medical chart, may quietly influence whether you'll have a stroke before you turn sixty. A large genetic study published in 2022 found that people carrying the type A blood group face a 16 percent higher risk of early stroke compared to those with other blood types—a discovery that emerged from one of the most comprehensive genomic analyses of stroke risk ever conducted.
Blood types are defined by chemicals that sit on the surface of red blood cells. The familiar categories—A, B, AB, and O—represent the presence or absence of two key molecular markers. Within these broad groups lie subtle variations, genetic mutations that create subtypes. Researchers wanted to know whether these variations correlated with stroke risk, so they assembled data from 48 separate genetic studies involving roughly 17,000 people who had experienced a stroke and nearly 600,000 people who had not. All participants were between 18 and 59 years old, the age range where early-onset stroke is rare enough to be medically distinct.
A genome-wide search identified two genetic locations strongly tied to early stroke risk. One of them sat precisely where the genes controlling blood type are located. When researchers zeroed in on blood-type genes specifically, the pattern became clear: people whose genetic code produced the A subgroup variant showed that 16 percent elevation in stroke likelihood before age 60. Those carrying the O1 variant, by contrast, showed a 12 percent reduction in risk. The findings were statistically robust, but researchers were careful to note that the absolute additional risk remained small—not a reason for people with type A blood to seek extra screening or live in heightened alarm.
The mechanism remains a mystery. Steven Kittner, a vascular neurologist at the University of Maryland and senior author of the study, acknowledged the gap in understanding. The connection likely involves blood-clotting factors—platelets, the cells that line blood vessel walls, and circulating proteins that all contribute to clot formation. Type A blood has been previously linked to slightly elevated venous thrombosis risk and to coronary artery calcification, both processes that restrict blood flow. But why the genetic code for type A blood would predispose someone to these clotting events is not yet clear.
Context matters here. In the United States, fewer than 800,000 people experience a stroke each year, and roughly three-quarters of those are people 65 and older. Stroke risk roughly doubles with each decade after age 55. The people in this study came from North America, Europe, Japan, Pakistan, and Australia, though only 35 percent were of non-European ancestry—a limitation that may affect how broadly these findings apply.
A striking secondary finding emerged when researchers compared early-onset strokes to late-life strokes. They analyzed data from about 9,300 people over 60 who had stroked and 25,000 controls over 60 who had not. In this older group, the type A blood association with stroke risk disappeared. This suggests that strokes occurring in younger people operate through different biological mechanisms than those in older people. Early strokes are less likely to result from atherosclerosis—the slow buildup of fatty deposits in arteries—and more likely to stem from clot formation itself. Late-life strokes, by contrast, often involve the accumulated arterial damage of decades.
The study also found that type B blood carriers showed an 11 percent higher stroke risk regardless of age, a finding that complicates the picture further and suggests multiple pathways linking blood type to stroke. Kittner and his colleagues called for larger, more diverse studies to clarify why blood type matters and whether these genetic associations hold across different populations. The work, published in the journal Neurology, opens a door to understanding stroke risk that had previously gone unexamined at this scale.
Notable Quotes
We still don't know why blood type A would confer a higher risk, but it likely has something to do with blood-clotting factors like platelets and cells that line the blood vessels as well as other circulating proteins.— Steven Kittner, vascular neurologist, University of Maryland
We clearly need more follow-up studies to clarify the mechanisms of increased stroke risk.— Steven Kittner
The Hearth Conversation Another angle on the story
So if I have type A blood, should I be worried?
The study found a 16 percent increase in risk, but that's relative risk. Your absolute risk of having a stroke before 60 is still quite low. Most strokes happen in people over 65. It's not a reason to panic or demand screening.
Then why does this matter? Why publish it?
Because it's a clue. If we understand why type A blood increases clot formation, we might develop better preventive treatments—not just for type A people, but for anyone at clot risk.
The study looked at people from five continents but mostly Europeans. Does that weaken the findings?
It does. We don't know if the same genetic association holds equally in people of African, Asian, or Indigenous ancestry. That's why the researchers explicitly called for more diverse studies.
You mentioned early strokes work differently than late strokes. What's the difference?
Young people who stroke usually have a clot form suddenly in a vessel. Older people often stroke because their arteries have narrowed over decades from fatty buildup. Same outcome, different cause. Blood type seems to matter mainly for the clot pathway.
Is there anything someone with type A blood can actually do?
The same things anyone does to reduce stroke risk—manage blood pressure, don't smoke, exercise, eat well. This study doesn't change that advice. It just adds one more piece to understanding who's vulnerable and why.